Article
A cancer drug wish list
Rating:
0.0
Views:
38
Likes:
1
Library:
1
Shiva Malek, head of oncology at Novartis Institutes for Biomedical Research, discusses her drug development ambitions — including drugging transcription factors, tackling drug resistance and curing KRAS-mutant cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value